Compare Cronos Group Inc (CRON) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs PepsiCo, Inc. — how do they compare? Cronos Group Inc trades at $2.74 (market cap $1.02B), while PepsiCo, Inc. trades at $135.87 (market cap $184.87B). The key difference: PepsiCo, Inc. is far larger — about 181.2× Cronos Group Inc's market cap, and PepsiCo, Inc. pays a 4.37% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | PEP | |
|---|---|---|
Market Cap | $1.02B | $184.87B |
Sector | Health | Consumer Staples |
52-Week High | $3.27 | $170.44 |
52-Week Low | $1.95 | $133.81 |
Enterprise Value | $203.29M | $227.37B |
Dividend Yield | — | 4.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.
Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.
PepsiCo (PEP) trades at $138.49, up 0.81% with bearish technical signals but strong fundamentals. The company reported three consecutive quarterly earnings beats and maintains robust profitability with 10.78% net margin and 51.59% ROE. Recent news highlights price adjustments for snack products and sponsorship changes, while analysts maintain a consensus price target of $159.27 with 33% buy ratings.
PEP offers stable dividend income and operational strength but faces near-term technical pressure and competitive pricing challenges. The stock trades below analyst targets with upside potential, though investors should monitor North American performance trends and margin sustainability amid ongoing business transformation initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
